866-997-4948(US-Canada Toll Free)

Veterinary Biologics Market - Global Industry Analysis and Opportunity Assessment, 2019-2029

Published By :

Future Market Insights

Published Date : Jan 2020

Category :

Healthcare

No. of Pages : 232 Pages

A recent market study published by Future Market Insights (FMI) on the veterinary biologics market includes global industry analysis for 2014-2018 and opportunity assessment for 2019-2029, and delivers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical as well as current growth parameters of the veterinary biologics market, growth prospects are obtained with maximum precision.

Chapter 01 – Executive Summary

The report initiates with the executive summary of the veterinary biologics market, which includes a summary of key findings and statistics of the market. It also includes market size and revenue distribution of market segment of the veterinary biologics market.

Chapter 02 – Market Introduction

Readers can find the definition and a detailed segmentation of the veterinary biologics market in this chapter, which will help them understand the basic information about the market.

Chapter 03 – Key Market Trends

This chapter explains the key trends that are expected to influence the growth of the veterinary biologics market over the forecast period. Moreover, in-depth information about the market dynamics and their impact analysis on the market have been provided in the successive section.

Chapter 04 – Key Success Factors

This section includes premium insights such as epidemiology of various veterinary diseases, region wise regulations for veterinary biologics.

Chapter 05 - Global Veterinary Biologics Market Value Analysis 2014-2018 and Opportunity Assessment, 2019-2029

This section explains the global market value analysis and forecast for the veterinary biologics during the forecast period. This chapter includes a detailed analysis of the historical veterinary biologics market.

Chapter 06 – Market Background

This section includes premium insights such as macroeconomic factors, drivers, opportunity and restraints.

 Chapter 07 – Global Veterinary Biologics Market Value Analysis 2014-2018 & Opportunity Assessment 2019-2029 by Product

Based on product, the veterinary biologics market is segmented into vaccines, bacterial extracts, monoclonal antibody, immunomodulators and allergenic extracts. In this chapter, readers can find information about the key trends and developments in the veterinary biologics and market attractiveness analysis based on product.

Chapter 08 – Global Veterinary Biologics Analysis 2014-2018 & Opportunity Assessment 2019-2029 by Animal Type

This chapter provides details about the veterinary biologics market based on Animal Type, and has been classified into companion animals, livestock animals and equine animals. In this chapter, readers can understand the market attractiveness analysis based on animal Type.

Chapter 09 – Global Veterinary Biologics Analysis 2014-2018 & Opportunity Assessment 2019-2029 by Distribution Channel

This chapter provides details about the veterinary biologics market based on distribution channel, and has been classified into veterinary clinics, veterinary hospitals, veterinary research institutes and retail pharmacies. In this chapter, readers can understand the market attractiveness analysis based on distribution channel.

Chapter 10 – Global Veterinary Biologics Market Value & Volume Analysis 2014-2018 & Opportunity Assessment 2019-2029 by Region

This chapter explains how the veterinary biologics market will grow across various geographic regions such as North America, Latin America, Europe, East Asia, South Asia, Oceania, and Middle East & Africa (MEA).

Chapter 11 – North America Veterinary Biologics Market Value & Volume Analysis 2014-2018 & Opportunity Assessment 2019-2029

This chapter includes a detailed analysis of growth of the North America Veterinary Biologics market, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find the pricing analysis, regional trends, and market growth based on the application and countries in North America.

Chapter 12 – Latin America Veterinary Biologics Market Value & Volume Analysis 2014-2018 & Opportunity Assessment 2019-2029

This chapter provides the growth scenario of the veterinary biologics market in Latin American countries such as Argentina, Brazil, Mexico, and the Rest of Latin America. Along with this, assessment of the market across target segments has been provided.

Chapter 13 – Europe Veterinary Biologics Market Value & Volume Analysis 2014-2018 & Opportunity Assessment 2019-2029

This chapter provides the growth scenario of the veterinary biologics market in Europe in several countries such as Germany, the U.K., France, Spain, Italy, BENELUX, Russia and the Rest of Europe are included in this chapter.

Chapter 14 – East Asia Veterinary Biologics Market Value & Volume Analysis 2014-2018 & Opportunity Assessment 2019-2029

This chapter provides the growth scenario of the veterinary biologics market in East Asia in several countries such as China, Japan and South Korea are included in this chapter.

Chapter 15 – South Asia Veterinary Biologics Market Value & Volume Analysis 2014-2018 & Opportunity Assessment 2019-2029

This chapter highlights the growth of the veterinary biologics in South Asia by focusing on India, Thailand, Indonesia, Malaysia, rest of South Asia. This section also help readers understand the key factors that are responsible for the growth of the veterinary biologics market in South Asia.

Chapter 16 – Oceania Veterinary Biologics Market Value & Volume Analysis 2014-2018 & Opportunity Assessment 2019-2029

This chapter highlights the growth of the veterinary biologics in Australia and New Zealand. This section also help readers understand the key factors that are responsible for the growth of the veterinary biologics market in Oceania.

Chapter 17 – MEA Veterinary Biologics Market Value & Volume Analysis 2014-2018 & Opportunity Assessment 2019-2029

This chapter provides information about how the veterinary biologics market will grow in major countries in the MEA region such as GCC Countries, South Africa, and the Rest of MEA, during the forecast period (2019-2029).

Chapter 18 – Market Structure Analysis

In this chapter, readers can find tier wise contribution of key market players along with their company market share.

Chapter 19 – Competition Analysis

In this chapter, readers can find a comprehensive list of all the prominent stakeholders in the veterinary biologics market, along with a detailed information about each company, which includes company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report are Ceva, Boehringer Ingelheim, Boehringer Ingelheim, Merck Animal Health, etc.

Chapter 20 – Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provides a base to the information and statistics included in the veterinary biologics report.

Chapter 21 – Research Methodology

This chapter help readers understand the research methodology followed to obtain various conclusions as well as important qualitative and quantitative information about the veterinary biologics.

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Key Market Trends

3.1. Key Trends Impacting the Market

4. Key Success Factors

4.1. Regulatory Scenario

5. Global Veterinary Biologics Market Demand (in Value or Size in US$ Mn) Analysis 2014-2018and Forecast, 2019-2029

5.1. Historical Market Value (US$ Mn) Analysis, 2014-2018

5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029

5.2.1. Y-o-Y Growth Trend Analysis

5.2.2. Absolute $ Opportunity Analysis

6. Market Background

6.1. Macro-Economic Factors

6.2. Forecast Factors - Relevance & Impact

6.3. Market Dynamics

6.3.1. Drivers

6.3.2. Restraints

6.3.3. Opportunity Analysis

7. Global Veterinary Biologics Market Analysis 2014-2018 and Forecast 2019-2029, by Product Type 

7.1. Introduction / Key Findings

7.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2014 - 2018

7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2019 - 2029

7.3.1. Vaccines

7.3.1.1. Attenuated Live Vaccines

7.3.1.2. Conjugate Vaccines

7.3.1.3. Inactivated Vaccines

7.3.1.4. Subunit Vaccines

7.3.1.5. Toxoid Vaccines

7.3.1.6. DNA Vaccines

7.3.1.7. Recombinant Vaccines

7.3.2. Bacterial Extracts

7.3.3. Monoclonal Antibody

7.3.4. Immunomodulators

7.3.4.1. Cytokines

7.3.4.2. Others

7.3.5. Allergenic Extracts

7.4. Market Attractiveness Analysis By Product Type 

8. Global Veterinary Biologics Market Analysis 2014-2018 and Forecast 2019-2029, by Animal Type 

8.1. Introduction / Key Findings

8.2. Historical Veterinary Biologics Market Size (US$ Mn) Analysis By Animal Type, 2014 - 2018

8.3. Current and Future Veterinary Biologics Market Size (US$ Mn) Analysis By Animal Type, 2019 - 2029

8.3.1. Companion Animals

8.3.1.1. Canine

8.3.1.2. Avian

8.3.1.3. Feline

8.3.2. Livestock Animals

8.3.2.1. Aquatic

8.3.2.2. Bovine

8.3.2.3. Porcine

8.3.2.4. Ovine/Caprine

8.3.2.5. Poultry

8.3.3. Equine

8.4. Market Attractiveness Analysis of Antitoxins Market By Animal Type

9. Global Veterinary Biologics - Cytokines Market Analysis 2014-2018 and Forecast 2019-2029, by Animal Type 

9.1. Historical Cytokines Market Size (US$ Mn) Analysis By Animal Type, 2014 - 2018

9.2. Current and Future Cytokines Market Size (US$ Mn) Analysis By Animal Type, 2019 - 2029

9.2.1. Companion Animals

9.2.1.1. Canine

9.2.1.2. Avian

9.2.1.3. Feline

9.2.2. Livestock Animals

9.2.2.1. Aquatic

9.2.2.2. Bovine

9.2.2.3. Porcine

9.2.2.4. Ovine/Caprine

9.2.2.5. Poultry

9.2.3. Equine 

10. Global Veterinary Biologics - Other Immunomodulatory Biologics Market Analysis 2014-2018 and Forecast 2019-2029, by Animal Type 

10.1. Historical Other Immuno-Suppressing Agents Market Size (US$ Mn) Analysis By Animal Type, 2014 - 2018

10.2. Current and Future Other Immuno-Suppressing Agents Market Size (US$ Mn) Analysis By Animal Type, 2019 - 2029

10.2.1. Companion Animals

10.2.1.1. Canine

10.2.1.2. Avian

10.2.1.3. Feline

10.2.2. Livestock Animals

10.2.2.1. Aquatic

10.2.2.2. Bovine

10.2.2.3. Porcine

10.2.2.4. Ovine/Caprine

10.2.2.5. Poultry

10.2.3. Equine 

11. Global Veterinary Biologics Market Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel 

11.1. Introduction / Key Findings

11.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2014 - 2018

11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2019 – 2029

11.3.1. Veterinary Clinics

11.3.2. Veterinary Hospitals

11.3.3. Veterinary Research Institutes

11.3.4. Retail Pharmacies

11.4. Market Attractiveness Analysis By Distribution Channel

12. Global Veterinary Biologics Market Analysis 2014-2018 and Forecast 2019-2029, By Region

12.1. Introduction

12.2. Historical Market Size (US$ Mn) Analysis By Animal Type, 2014 - 2018

12.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 - 2029

12.3.1. North America

12.3.2. Latin America

12.3.3. Europe

12.3.4. South Asia

12.3.5. East Asia

12.3.6. Oceania

12.3.7. Middle East & Africa

12.4. Market Attractiveness Analysis By Region

13. North America Veterinary Biologics Market Analysis 2014-2018 and Forecast 2019-2029

13.1. Introduction

13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2018

13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029

13.3.1. By Country

13.3.1.1. U.S.

13.3.1.2. Canada

13.3.2. By Product Type

13.3.3. By Animal Type

13.3.4. By Distribution Channel

13.4. Market Attractiveness Analysis

13.4.1. By Country

13.4.2. By Product Type

13.4.3. By Animal Type

13.4.4. By Distribution Channel

13.5. Key Market Participants - Intensity Mapping

13.6. Drivers and Restraints - Impact Analysis

14. Latin America Veterinary Biologics Market Analysis 2014-2018 and Forecast 2019-2029

14.1. Introduction

14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2018

14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029

14.3.1. By Country

14.3.1.1. Brazil

14.3.1.2. Mexico

14.3.1.3. Rest of Latin America

14.3.2. By Product Type

14.3.3. By Animal Type

14.3.4. By Distribution Channel

14.4. Market Attractiveness Analysis

14.4.1. By Country

14.4.2. By Product Type

14.4.3. By Animal Type

14.4.4. By Distribution Channel

14.5. Key Market Participants - Intensity Mapping

14.6. Drivers and Restraints - Impact Analysis

15. Europe Veterinary Biologics Market Analysis 2014-2018 and Forecast 2019-2029

15.1. Introduction

15.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2018

15.3. Market Size (US$ Mn) and By Market Taxonomy, 2019 - 2029

15.3.1. By Country

15.3.1.1. Germany

15.3.1.2. Italy

15.3.1.3. France

15.3.1.4. U.K.

15.3.1.5. Spain

15.3.1.6. BENELUX

15.3.1.7. Russia

15.3.1.8. Rest of Europe

15.3.2. By Product Type

15.3.3. By Animal Type

15.3.4. By Distribution Channel

15.4. Market Attractiveness Analysis

15.4.1. By Country

15.4.2. By Product Type

15.4.3. By Animal Type

15.4.4. By Distribution Channel

15.5. Key Market Participants - Intensity Mapping

15.6. Drivers and Restraints - Impact Analysis

16. South Asia Veterinary Biologics Market Analysis 2014-2018 and Forecast 2019-2029

16.1. Introduction

16.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2018

16.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029

16.3.1. By Country

16.3.1.1. India

16.3.1.2. Thailand

16.3.1.3. Indonesia

16.3.1.4. Malaysia

16.3.1.5. Rest of South Asia

16.3.2. By Product Type

16.3.3. By Animal Type

16.3.4. By Distribution Channel

16.4. Market Attractiveness Analysis

16.4.1. By Country

16.4.2. By Product Type

16.4.3. By Animal Type

16.4.4. By Distribution Channel

16.5. Key Market Participants - Intensity Mapping

16.6. Drivers and Restraints - Impact Analysis

17. East Asia Veterinary Biologics Market Analysis 2014-2018 and Forecast 2019-2029

17.1. Introduction

17.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2018

17.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029

17.3.1. By Country

17.3.1.1. China

17.3.1.2. Japan

17.3.1.3. South Korea

17.3.2. By Product Type

17.3.3. By Animal Type

17.3.4. By Distribution Channel

17.4. Market Attractiveness Analysis

17.4.1. By Country

17.4.2. By Product Type

17.4.3. By Animal Type

17.4.4. By Distribution Channel

17.5. Key Market Participants - Intensity Mapping

17.6. Drivers and Restraints - Impact Analysis

18. Oceania Veterinary Biologics Market Analysis 2014-2018 and Forecast 2019-2029

18.1. Introduction

18.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2018

18.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029

18.3.1. By Country

18.3.1.1. Australia

18.3.1.2. New Zealand

18.3.2. By Product Type

18.3.3. By Animal Type

18.3.4. By Distribution Channel

18.4. Market Attractiveness Analysis

18.4.1. By Country

18.4.2. By Product Type

18.4.3. By Animal Type

18.4.4. By Distribution Channel

18.5. Key Market Participants - Intensity Mapping

18.6. Drivers and Restraints - Impact Analysis

19. MEA Veterinary Biologics Market Analysis 2014-2018 and Forecast 2019-2029

19.1. Introduction

19.2. Pricing Analysis

19.3. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2018

19.4. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029

19.4.1. By Country

19.4.1.1. GCC Countries

19.4.1.2. Turkey

19.4.1.3. Northern Africa

19.4.1.4. South Africa

19.4.1.5. Rest of MEA

19.4.2. By Product Type

19.4.3. By Animal Type

19.4.4. By Distribution Channel

19.5. Market Attractiveness Analysis

19.5.1. By Country

19.5.2. By Product Type

19.5.3. By Animal Type

19.5.4. By Distribution Channel

19.6. Key Market Participants - Intensity Mapping

19.7. Drivers and Restraints - Impact Analysis

20. Emerging Countries Veterinary Biologics Market Analysis 2014-2018 and Forecast 2019-2029

20.1. Introduction

20.1.1. Market Value Proportion Analysis, By Key Countries

20.1.2. Global Vs. Country Growth Comparison

20.2. China Veterinary Biologics Market Analysis

20.2.1. Introduction

20.2.2. PEST Analysis

20.2.3. Market Value Proportion Analysis by Market Taxonomy

20.2.4. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

20.2.4.1. By Product Type

20.2.4.2. By Animal Type

20.2.4.3. By Distribution Channel

20.3. India Veterinary Biologics Market Analysis

20.3.1. Introduction

20.3.2. PEST Analysis

20.3.3. Market Value Proportion Analysis by Market Taxonomy

20.3.4. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

20.3.4.1. By Product Type

20.3.4.2. By Animal Type

20.3.4.3. By Distribution Channel

20.4. Brazil Veterinary Biologics Market Analysis

20.4.1. Introduction

20.4.2. PEST Analysis

20.4.3. Market Value Proportion Analysis by Market Taxonomy

20.4.4. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

20.4.4.1. By Product Type

20.4.4.2. By Animal Type

20.4.4.3. By Distribution Channel

21. Market Structure Analysis

21.1. Market Analysis by Tier of Companies

21.2. Market Concentration

21.3. Market Share Analysis of Top Players

21.4. Market Presence Analysis

21.4.1. Product foot print by Players

21.4.2. Channel Foot Print by Players

22. Competition Analysis

22.1. Competition Dashboard

22.2. Competition Benchmarking

22.3. Competition Deep Dive 

22.3.1. Elanco Animal Health

22.3.1.1. Overview

22.3.1.2. Product Portfolio

22.3.1.3. Profitability by Market Segments (Product/Channel/Region)

22.3.1.4. Sales Footprint

22.3.1.5. Strategy Overview

22.3.1.5.1. Marketing Strategy

22.3.1.5.2. Product Strategy

22.3.1.5.3. Channel Strategy

22.3.2. Ceva

22.3.2.1. Overview

22.3.2.2. Product Portfolio

22.3.2.3. Profitability by Market Segments (Product/Channel/Region)

22.3.2.4. Sales Footprint

22.3.2.5. Strategy Overview

22.3.2.5.1. Marketing Strategy

22.3.2.5.2. Product Strategy

22.3.2.5.3. Channel Strategy

22.3.3. Phibro Animal Health Corporation 

22.3.3.1. Overview

22.3.3.2. Product Portfolio

22.3.3.3. Profitability by Market Segments (Product/Channel/Region)

22.3.3.4. Sales Footprint

22.3.3.5. Strategy Overview

22.3.3.5.1. Marketing Strategy

22.3.3.5.2. Product Strategy

22.3.3.5.3. Channel Strategy

22.3.4. Boehringer Ingelheim

22.3.4.1. Overview

22.3.4.2. Product Portfolio

22.3.4.3. Profitability by Market Segments (Product/Channel/Region)

22.3.4.4. Sales Footprint

22.3.4.5. Strategy Overview

22.3.4.5.1. Marketing Strategy

22.3.4.5.2. Product Strategy

22.3.4.5.3. Channel Strategy

22.3.5. Zoetis, Inc.

22.3.5.1. Overview

22.3.5.2. Product Portfolio

22.3.5.3. Profitability by Market Segments (Product/Channel/Region)

22.3.5.4. Sales Footprint

22.3.5.5. Strategy Overview

22.3.5.5.1. Marketing Strategy

22.3.5.5.2. Product Strategy

22.3.5.5.3. Channel Strategy

22.3.6. Merck Animal Health

22.3.6.1. Overview

22.3.6.2. Product Portfolio

22.3.6.3. Profitability by Market Segments (Product/Channel/Region)

22.3.6.4. Sales Footprint

22.3.6.5. Strategy Overview

22.3.6.5.1. Marketing Strategy

22.3.6.5.2. Product Strategy

22.3.6.5.3. Channel Strategy

22.3.7. Virbac

22.3.7.1. Overview

22.3.7.2. Product Portfolio

22.3.7.3. Profitability by Market Segments (Product/Channel/Region)

22.3.7.4. Sales Footprint

22.3.7.5. Strategy Overview

22.3.7.5.1. Marketing Strategy

22.3.7.5.2. Product Strategy

22.3.7.5.3. Channel Strategy

22.3.8. Hester Biosciences Limited

22.3.8.1. Overview

22.3.8.2. Product Portfolio

22.3.8.3. Profitability by Market Segments (Product/Channel/Region)

22.3.8.4. Sales Footprint

22.3.8.5. Strategy Overview

22.3.8.5.1. Marketing Strategy

22.3.8.5.2. Product Strategy

22.3.8.5.3. Channel Strategy

22.3.9. Colorado Serum Company

22.3.9.1. Overview

22.3.9.2. Product Portfolio

22.3.9.3. Profitability by Market Segments (Product/Channel/Region)

22.3.9.4. Sales Footprint

22.3.9.5. Strategy Overview

22.3.9.5.1. Marketing Strategy

22.3.9.5.2. Product Strategy

22.3.9.5.3. Channel Strategy

22.3.10. Addison Biological Laboratory, Inc.

22.3.10.1. Overview

22.3.10.2. Product Portfolio

22.3.10.3. Profitability by Market Segments (Product/Channel/Region)

22.3.10.4. Sales Footprint

22.3.10.5. Strategy Overview

22.3.10.5.1. Marketing Strategy

22.3.10.5.2. Product Strategy

22.3.10.5.3. Channel Strategy

22.3.11. American Animal Health, Inc.

22.3.11.1. Overview

22.3.11.2. Product Portfolio

22.3.11.3. Profitability by Market Segments (Product/Channel/Region)

22.3.11.4. Sales Footprint

22.3.11.5. Strategy Overview

22.3.11.5.1. Marketing Strategy

22.3.11.5.2. Product Strategy

22.3.11.5.3. Channel Strategy

22.3.12. HIPRA

22.3.12.1. Overview

22.3.12.2. Product Portfolio

22.3.12.3. Profitability by Market Segments (Product/Channel/Region)

22.3.12.4. Sales Footprint

22.3.12.5. Strategy Overview

22.3.12.5.1. Marketing Strategy

22.3.12.5.2. Product Strategy

22.3.12.5.3. Channel Strategy

22.3.13. Bimeda Inc. (Texas Vet Lab, Inc.)

22.3.13.1. Overview

22.3.13.2. Product Portfolio

22.3.13.3. Profitability by Market Segments (Product/Channel/Region)

22.3.13.4. Sales Footprint

22.3.13.5. Strategy Overview

22.3.13.5.1. Marketing Strategy

22.3.13.5.2. Product Strategy

22.3.13.5.3. Channel Strategy

23. Assumptions and Acronyms Used

24. Research Methodology

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *